Abstract：Objective To study the clinical efficacy and safety of Xiangjia Pills in the treatment of advanced gastric cancer. Methods Seventy-two patients with advanced gastric cancer who had failed second-line treatment in the Department of Oncology, Danyang Hospital of Traditional Chinese Medicine from June 2014 to May 2018 were included, and they were divided into the experimental group and the control group by random number table. There were 51 cases in the experimental group and 21 cases in the control group. The experimental group was treated with Xiangjia Pills combined with the best supportive treatment, which lasted for 15 consecutive days for one course of treatment, and at least two courses of treatment, until the disease progressed significantly or the drug could not be tolerated. The control group was treated with the best supportive treatment. The fatigue, poor appetite, Numerical rating scale (NRS) score, Karnofsky functional status (KPS) score, tumor markers, toxicity and side effects, and overall survival (OS) of patients in both groups were observed. Results In the experimental group, 51 patients entered the study, of which 2 cases fell out and 49 cases completed the study. All 21 patients in the control group completed the study. The effective rates of fatigue and poor appetite after treatment in the experimental group were significantly higher than those in the control group, with highly statistically significant differences (P < 0.01). There was no significant difference in NRS score between the experiment group and the control group after treatment (P ＞ 0.05). After treatment, the KPS score of the experimental group was higher than that of the control group, with statistically significant difference (P < 0.05). No significant blood and liver and kidney toxicity were observed in the experimental group, and 42.86% of the patients had decreased tumor markers. The average OS in the experimental group was longer than that in the control group, with statistically significant difference (P ＜ 0.05). Conclusion Xiangjia Pills can effectively treat advanced gastric cancer, increase the quality of life of patients, improve the symptoms of fatigue and poor appetite for gastric cancer. To some extent, the survival period is prolonged, and there is no obvious toxic side effect. It is worthy to promotion.
马继恒 王国方. 香甲丸治疗晚期胃癌的效果及安全性分析[J]. 中国医药导报, 2020, 17(3): 115-119.
MA Jiheng WANG Guofang. Effect and safety analysis of Xiangjia Pills in the treatment of advanced gastric cancer. 中国医药导报, 2020, 17(3): 115-119.
京公网安备 11010502046598号